Development of LPS antagonistic therapeutics: synthesis and evaluation of glucopyranoside-spacer-amino acid motifs

Sophon Kaeothip; Geeta Paranjape; Shana E. Terrill; Aileen F. G. Bongat; Maria L. D. Udan; Teerada Kamkhachorn; Hope L. Johnson; Michael R. Nichols; Alexei V. Demchenko

doi:10.1039/C1RA00145K

Development of LPS antagonistic therapeutics: synthesis and evaluation of glucopyranoside-spacer-amino acid motifs

Sophon Kaeothip
, Geeta Paranjape
, Shana E. Terrill
, Aileen F. G. Bongat
, Maria L. D. Udan
, Teerada Kamkhachorn
, Hope L. Johnson
, Michael R. Nichols
, Alexei V. Demchenko

University of Missouri-St. Louis

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	RSC Advances
Volume	1
DOIs	https://doi.org/10.1039/C1RA00145K
State	Published - Aug 9 2011

Disciplines

Biochemistry

Access to Document

10.1039/C1RA00145KLicense: Unspecified

c1ra00145k.pdfFinal published version, 473 KBLicense: Unspecified

Cite this

@article{579dcc659d4441b8833233f64a6635b2,

title = "Development of LPS antagonistic therapeutics: synthesis and evaluation of glucopyranoside-spacer-amino acid motifs",

author = "Sophon Kaeothip and Geeta Paranjape and Terrill, \{Shana E.\} and Bongat, \{Aileen F. G.\} and Udan, \{Maria L. D.\} and Teerada Kamkhachorn and Johnson, \{Hope L.\} and Nichols, \{Michael R.\} and Demchenko, \{Alexei V.\}",

note = "Sepsis is a serious medical condition characterized by bacterial infection and a subsequent massive systemic inflammatory response. The release of proinflammatory products and mediators from responding innate immune cells, such as mononuclear phagocytes, directly contributes to the pathogenesis of sepsis. Th",

year = "2011",

month = aug,

day = "9",

doi = "10.1039/C1RA00145K",

language = "American English",

volume = "1",

journal = "RSC Advances",

}

TY - JOUR

T1 - Development of LPS antagonistic therapeutics: synthesis and evaluation of glucopyranoside-spacer-amino acid motifs

AU - Kaeothip, Sophon

AU - Paranjape, Geeta

AU - Terrill, Shana E.

AU - Bongat, Aileen F. G.

AU - Udan, Maria L. D.

AU - Kamkhachorn, Teerada

AU - Johnson, Hope L.

AU - Nichols, Michael R.

AU - Demchenko, Alexei V.

N1 - Sepsis is a serious medical condition characterized by bacterial infection and a subsequent massive systemic inflammatory response. The release of proinflammatory products and mediators from responding innate immune cells, such as mononuclear phagocytes, directly contributes to the pathogenesis of sepsis. Th

PY - 2011/8/9

Y1 - 2011/8/9

UR - http://pubs.rsc.org/en/Content/ArticleLanding/RA/2011/C1RA00145K#!

U2 - 10.1039/C1RA00145K

DO - 10.1039/C1RA00145K

M3 - Article

VL - 1

JO - RSC Advances

JF - RSC Advances

ER -

Development of LPS antagonistic therapeutics: synthesis and evaluation of glucopyranoside-spacer-amino acid motifs

Disciplines

Access to Document

Other files and links

Cite this